Our interactive webinars that feature key developments in clinical diagnostics

  1. Home
  2. Science
  3. How Biomarkers Transform Genetic Diagnostics

"How Biomarkers Transform Genetic Diagnostics: Fast and Precise Answers for Niemann-Pick Disease"

Throughout the webinar, Dr. Tobias Böttcher provided an overview of how multiomic biomarkers play an essential role in early diagnosis, prediction, and therapeutic monitoring of Niemann-Pick Disease Type A, B, and C.

Key Topics:

  • Clinical Aspects of Niemann-Pick Disease (A, B, & C)
  • Modern Pathways and the Multiomic Biomarker Approach
  • Clinical Cases

Fill in the form to watch the CentoTalk on demand

By clicking Watch Now! you agree to receive the latest news and developments in clinical diagnostics and scientific breakthroughs in the rare disease field.

You will receive an email with a subscription confirmation link. Once you have clicked on that link, we will inform you about our products, services and upcoming events per e-mail. You can unsubscribe from our newsletter with effect for the future at any time using the unsubscribe link contained in every newsletter.

Our speaker

Tobias Böttcher, MD

Tobias Boettcher completed his internship in Neurology at the Dept. of Neurology, University of Rostock, Germany. During this time, he received a research grant from the German Academy of Natural Sciences Leopoldina, with projects at the Dept. of Physiology/Pharmacology, Karolinska Institute, and the Dept. of Neurology, University of Goettingen. In 2005, Dr. Boettcher received his Board Certification in Neurology, and subsequently worked for four years as a Registrar Neurologist at the Dept. of Neurology, Dietrich-Bonhoeffer-Hospital, Neubrandenburg.

Since September 2017, Dr. Boettcher has worked as a Clinical Neurologist at the Outpatient Medical Center of the Johanna-Odebrecht-Stiftung, Greifswald, at the specialized Outpatient Department for Neurogenetic Diseases and LSDs. Dr. Boettcher has co-authored 48 peer-reviewed scientific publications (19 in the scope of LSDs). Since 1997, he has developed vast experience in the field of LSDs through his work in patient care (outpatient departments), basic research (Neurogenetic Laboratory, University of Rostock), and diagnostics (CENTOGENE).